Pfizer Denies Exploitation of COVID-19 Vaccine in US Elections

Sources familiar with Pfizer, a US therapeutic giant, revealed today, Friday, that it would not apply for emergency authorization of its coronavirus (COVID-19) vaccine until late November.

The chief executive of Pfizer said on Friday that the company would not apply for emergency authorization of its Coronavirus vaccine before the third week of November.

He ruled out President Trump’s assertion that a vaccine would be ready before Election Day on Nov. 3.

In a statement posted to the company website, the chief executive, Dr. Albert Bourla, said that although Pfizer could have preliminary numbers by the end of October about whether the vaccine works, it would still need to collect safety and manufacturing data that will stretch the timeline to at least the third week of November.

Close watchers of the vaccine race had already known that Pfizer wouldn’t be able to meet the requirements of the  US Food and Drug Administration (FDA) by the end of October.

The company had aligned its messaging with that of the president, who has made no secret of his desire for an approved vaccine before the election.

President Trump has even singled out the company by name and said he had talked to Dr. Bourla, whom he called a “great guy.”

Some scientists applauded Pfizer’s announcement.

“This is good, really good,” said Dr. Eric Topol, a clinical trial expert at Scripps Research in San Diego, who was one of 60 public health officials and others in the medical community who signed a letter to Pfizer urging it not to rush its vaccine.

He said company officials had assured him that a vaccine would most likely not be authorized before the election, but the letter on Friday is “even more solid about their not being part of any political machinations.”

Dr. Bourla has pushed back against any suggestion that Pfizer’s vaccine timeline was politically motivated.

Earlier this month, Dr. Bourla published an open letter to employees that said he “would never succumb to political pressure” and expressing disappointment that “we find ourselves in the crucible of the U.S. presidential election.”